Carotid intima-media thickness and arterial stiffness in type 1 diabetic patients with and without microangiopathy

Archives of Medical Science

Volumn 8, Issue 3, 2012, Pages 484-490

  Rogowicz Frontczak, Anita ^a   Araszkiewicz, Aleksandra ^a   Pilacinski, Stanislaw ^a   Zozulinska Ziolkiewicz, Dorota ^a   Wykretowicz, Andrzej ^a   Wierusz Wysocka, Bogna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Arterial stiffness; Carotid intima media thickness; Microangiopathy; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; AGE; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; AUGMENTATION INDEX; CAROTID ATHEROSCLEROSIS; CENTRAL AUGMENTATION INDEX; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL AUGMENTATION INDEX; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84863909362     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.29404     Document Type: Article

References (32)

1. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979; 2: 120-6. (Pubitemid 9238733)
2. Ruderman NB, Haudenschild C. Diabetes as an atherogenic factor. Prog Cardiovasc Dis 1984; 26: 373-412. (Pubitemid 14170169)
3. Orchard TJ, Olson JC, Erbey JR, et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2003; 26: 1374-9. (Pubitemid 36929165)
4. Soedamah-Muthu SS, Chaturvedi N, Toeller M, et al. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 2004; 27: 530-7. (Pubitemid 38174083)
5. Zozulinska D, Wierusz-Wysocka B. Hyperglycaemia and inflammation are culpritis of late diabetic complications. Arch Med Sci 2005; 1: 115-8.
6. Kłysik AB, Naduk-Kik J, Hrabec Z, Goś R, Hrabec E. Intraocular matrix metalloproteinase 2 and 9 in patients with diabetes mellitus with and without diabetic retinopathy. Arch Med Sci 2010; 6: 375-81.
7. Bilous R. Microvascular disease: what does the UKPDS tell us about diabetic nephropathy? Diabet Med 2008; 25 Suppl 2: 25-9. (Pubitemid 352020092)
8. Lin J, Glynn RJ, Rifai N, et al. Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial. Diabetes Care 2008; 31: 2338-43.
9. Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003; 23: 554-66. (Pubitemid 36438066)
10. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107: 2864-9. (Pubitemid 36705999)
11. Cohn JN, Quyyumi AA, Hollenberg NK, Jamerson KA. Surrogate markers for cardiovascular disease: functional markers. Circulation 2004; 109: IV31-46.
12. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-97.
13. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007; 49: S12-154.
14. Jarvisalo MJ, Raitakari M, Toikka JO, et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 2004; 109: 1750-5. (Pubitemid 38500678)
15. Anavekar NS, Gans DJ, Berl T, et al. Predictors of cardio - vascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. Kidney Int Suppl 2004; S50-5. (Pubitemid 43361431)
16. Basi S, Fesler P, Mimran A, Lewis JB. Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander? Diabetes Care 2008; 31 Suppl 2: S194-201.
17. Gul K, Ustun I, Aydin Y, et al. Carotid intima-media thickness and its relations with the complications in patients with type 1 diabetes mellitus. Anadolu Kardiyol Derg 2010; 10: 52-8.
18. Frost D, Friedl A, Beischer W. Determinants of early carotid atherosclerosis progression in young patients with type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes 2002; 110: 92-4. (Pubitemid 34296859)
19. Rema M, Mohan V, Deepa R, Ravikumar R. Association of carotid intima-media thickness and arterial stiffness with diabetic retinopathy: the Chennai Urban Rural Epidemiology Study (CURES-2). Diabetes Care 2004; 27: 1962-7. (Pubitemid 38989239)
20. Malecki MT, Osmenda G, Walus-Miarka M, et al. Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction. Eur J Clin Invest 2008; 38: 925-30.
21. Cardoso CR, Ferreira MT, Leite NC, Barros PN, Conte PH, Salles GF. Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients. Atherosclerosis 2009; 205: 472-6.
22. Ogawa O, Hiraoka K, Watanabe T, et al. Diabetic retinopathy is associated with pulse wave velocity, not with the augmentation index of pulse waveform. Cardiovasc Diabetol 2008; 7: 11.
23. Prince CT, Secrest AM, Mackey RH, Arena VC, Kingsley LA, Orchard TJ. Augmentation pressure and subendocardial viability ratio are associated with microalbuminuria and with poor renal function in type 1 diabetes. Diab Vasc Dis Res 2010; 7: 216-24.
24. Reasner CA. Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors. J Cardiovasc Pharmacol 2008; 52: 136-44.
25. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Diabetes 1999; 48: 383-90.
26. Larsen JR, Brekke M, Bergengen L, et al. Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes. Diabetologia 2005; 48: 776-9. (Pubitemid 40591235)
27. Fantin F, Mattocks A, Bulpitt CJ, Banya W, Rajkumar C. Is augmentation index a good measure of vascular stiffness in the elderly? Age Ageing 2007; 36: 43-8. (Pubitemid 47072032)
28. Wykretowicz A, Gerstenberger P, Guzik P, et al. Arterial stiffness in relation to subclinical atherosclerosis. Eur J Clin Invest 2009; 39: 11-6.
29. Wilkinson IB, MacCallum H, Rooijmans DF, et al. Increased augmentation index and systolic stress in type 1 diabetes mellitus. QJM 2000; 93: 441-8. (Pubitemid 30459922)
30. Greenfield JR, Samaras K, Chisholm DJ, Campbell LV. Effect of postprandial insulinemia and insulin resistance on measurement of arterial stiffness (augmentation index). Int J Cardiol 2007; 114: 50-6. (Pubitemid 44802886)
31. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-41. (Pubitemid 34163575)
32. Cheung N, Wong TY. Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res 2008; 27: 161-76.